Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K/AKT pathway

Introduction: Renal fibrosis is an endpoint event of various progressive chronic kidney diseases (CKD), but there are no effective antifibrotic treatments. Yiqi Qingre Gao (YQQRG) has shown potential in alleviating CKD, although its exact mechanism of action remains uncertain. This study aims to eva...

詳細記述

書誌詳細

主要な著者:	Qi Jin, Qian Li, Liping Yang, Fang Ma, Huimin Mao, Yuyang Wang, Tongtong Liu, Liang Peng, Ping Li, Yongli Zhan
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2025-03-01
シリーズ:	Frontiers in Pharmacology
主題:	Yiqi Qingre Gao chronic kidney diseases renal fibrosis PI3K/AKT network pharmacology
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1538061/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!